135 related articles for article (PubMed ID: 8701055)
1. Intrarectal glucantime.
Marsden PD
Rev Soc Bras Med Trop; 1996; 29(3):295. PubMed ID: 8701055
[No Abstract] [Full Text] [Related]
2. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Slappendel RJ; Teske E
Vet Q; 1997 Mar; 19(1):10-3. PubMed ID: 9225422
[TBL] [Abstract][Full Text] [Related]
3. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
[No Abstract] [Full Text] [Related]
4. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
Costa JM; Marsden PD
Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
[No Abstract] [Full Text] [Related]
5. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
Bogenrieder T; Lehn N; Landthaler M; Stolz W
Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
[TBL] [Abstract][Full Text] [Related]
6. Glucantime dosage.
Marsden PD; Romero GA
Trans R Soc Trop Med Hyg; 1996; 90(3):332. PubMed ID: 8758099
[No Abstract] [Full Text] [Related]
7. [Symptomatic hypokalemia caused by meglumine antimoniate].
Bouvresse S; Matichard E; Mahé E; Marinho E; Soria A; Devillière M; Descamps V; Crickx B
Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):387-8. PubMed ID: 17483764
[No Abstract] [Full Text] [Related]
8. Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil.
Marsden PD
Rev Inst Med Trop Sao Paulo; 1993; 35(6):589. PubMed ID: 7997767
[No Abstract] [Full Text] [Related]
9. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
10. [Treatment of cutaneous leishmaniasis with glucantime. Apropos of 9 cases].
Ramos García AN; Pérez Avila J; Pérez Ramos E; Díaz Hernández A; Ruiz Pérez A
Rev Cubana Med Trop; 1984; 36(2):151-9. PubMed ID: 6399595
[No Abstract] [Full Text] [Related]
11. [Antimonial treatments of leishmaniasis].
Oliveira Neto MP
Rev Soc Bras Med Trop; 2005; 38(5):446. PubMed ID: 16172767
[No Abstract] [Full Text] [Related]
12. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate.
Aste N; Pau M; Ferreli C; Biggio P
Br J Dermatol; 1998 Feb; 138(2):370-1. PubMed ID: 9602904
[No Abstract] [Full Text] [Related]
13. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
Momeni AZ; Aminjavaheri M
Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
[TBL] [Abstract][Full Text] [Related]
14. Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.
Mujtaba G; Khalid M
Int J Dermatol; 1999 Aug; 38(8):607-9. PubMed ID: 10487452
[No Abstract] [Full Text] [Related]
15. A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.
Harms G; Chehade AK; Douba M; Roepke M; Mouakeh A; Rosenkaimer F; Bienzle U
Trans R Soc Trop Med Hyg; 1991; 85(2):214-6. PubMed ID: 1909469
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
17. Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis.
Duque MC; Vasconcellos ÉC; Pimentel MI; Lyra MR; Pacheco SJ; Marzochi MC; Rosalino CM; Schubach AO
Rev Soc Bras Med Trop; 2016; 49(6):774-776. PubMed ID: 28001228
[TBL] [Abstract][Full Text] [Related]
18. Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony.
de Oliveira-Neto MP; Mattos Mda S
Rev Soc Bras Med Trop; 2006; 39(4):376-8. PubMed ID: 17119754
[TBL] [Abstract][Full Text] [Related]
19. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
Amato VS; de Oliveira LS; Silva AC; Machado FR; Amato JG; Nicodemo AC; Amato Neto V
Rev Soc Bras Med Trop; 1998; 31(2):221-4. PubMed ID: 9608241
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate.
Schubach Ade O; Marzochi KB; Moreira JS; Schubach TM; Araújo ML; Vale AC; Passos SR; Marzochi MC
Rev Soc Bras Med Trop; 2005; 38(3):213-7. PubMed ID: 15895170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
